Tumor volume and patient weight as predictors of outcome in children with intermediate risk rhabdomyosarcoma-Reference-Cited by-同舟云学术

Tumor volume and patient weight as predictors of outcome in children with intermediate risk rhabdomyosarcoma

Published:2010-12-14 Issue:11 Volume:117 Page:2541-2550
ISSN:0008-543X
Container-title:Cancer
language:en
Short-container-title:Cancer

Author:

Rodeberg David A.,Stoner Julie A.,Garcia-Henriquez Norbert,Randall R. Lor,Spunt Sheri L.,Arndt Carola A.,Kao Simon,Paidas Charles N.,Million Lynn,Hawkins Douglas S.

Publisher

Wiley

Subject

Cancer Research,Oncology

Reference16 articles.

1. Intergroup Rhabdomyosarcoma Study-IV: results for patients with nonmetastatic disease;Crist;J Clin Oncol.,2001

2. Rhabdomyosarcoma in children;Hayes-Jordan;Curr Opin Pediatr.,2009

3. Analysis of prognostic factors in patients with nonmetastatic rhabdomyosarcoma treated on Intergroup Rhabdomyosarcoma Studies III and IV: the Children's Oncology Group;Meza;J Clin Oncol.,2006

4. Treatment of nonmetastatic rhabdomyosarcoma in childhood and adolescence: third study of the International Society of Paediatric Oncology-SIOP. Malignant Mesenchymal Tumor 89;Stevens;J Clin Oncol.,2005

5. Rhabdomyosarcoma and undifferentiated sarcoma in the first 2 decades of life: a selective review of Intergroup Rhabdomyosarcoma Study Group experience and rationale for Intergroup Rhabdomyosarcoma Study V;Raney;J Pediatr Hematol Oncol.,2001

Cited by 19 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Correlation Between Tumor Volume and Hemoglobin Level in Gastrointestinal Stromal Tumor;Cureus;2023-05-16

2. Clinical Characteristics, Treatment Considerations, and Outcomes of Infants with Rhabdomyosarcoma;Cancers;2023-04-14

3. Rhabdomyosarcoma with isolated lung metastases: A report from the Soft Tissue Sarcoma Committee of the Children's Oncology Group;Pediatric Blood & Cancer;2023-03-14

4. Nutritional Status at Diagnosis as Predictor of Survival from Childhood Cancer: A Review of the Literature;Diagnostics;2022-09-28

5. Clinical group and modified TNM stage for rhabdomyosarcoma: A review from the Children's Oncology Group;Pediatric Blood & Cancer;2022-03-06